MedPath

Endothelial dysfunction and pregnancy complications in women with congenital heart disease: an addendum to the ZAHARA-II study (ZAHARED study)

Conditions
congenital heart disease
10010394
10007510
10010273
Registration Number
NL-OMON31812
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
195
Inclusion Criteria

All pregnant patients with a congenital heart anomaly presenting before 20 weeks of gestation in one of the participating medical centres; 60 healthy controls

Exclusion Criteria

Congenital heart disease: no exclusion criteria. Healthy women: Women who are on chronic medication; women who are under specialist control for chronic disease; drug addicts and smokers

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath